Elevation Oncology Statistics
Total Valuation
ELEV has a market cap or net worth of $35.94 million. The enterprise value is -$37.69 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, before market open.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ELEV has 59.12 million shares outstanding. The number of shares has increased by 81.44% in one year.
| Current Share Class | 59.12M |
| Shares Outstanding | 59.12M |
| Shares Change (YoY) | +81.44% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.69% |
| Owned by Institutions (%) | 61.08% |
| Float | 42.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.45.
| Current Ratio | 17.77 |
| Quick Ratio | 17.39 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.11 |
Financial Efficiency
Return on equity (ROE) is -63.67% and return on invested capital (ROIC) is -27.24%.
| Return on Equity (ROE) | -63.67% |
| Return on Assets (ROA) | -25.46% |
| Return on Capital (ROIC) | -27.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELEV has paid $43,000 in taxes.
| Income Tax | 43,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.22% in the last 52 weeks. The beta is 1.25, so ELEV's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +16.22% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 2.47 |
| Relative Strength Index (RSI) | 48.32 |
| Average Volume (20 Days) | 692,186 |
Short Selling Information
The latest short interest is 6.21 million, so 10.50% of the outstanding shares have been sold short.
| Short Interest | 6.21M |
| Short Previous Month | 5.95M |
| Short % of Shares Out | 10.50% |
| Short % of Float | 14.77% |
| Short Ratio (days to cover) | 9.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -42.01M |
| Pretax Income | -39.66M |
| Net Income | -41.95M |
| EBITDA | -41.98M |
| EBIT | -42.01M |
| Earnings Per Share (EPS) | -$0.79 |
Full Income StatementBalance Sheet
The company has $103.07 million in cash and $31.02 million in debt, giving a net cash position of $72.05 million or $1.22 per share.
| Cash & Cash Equivalents | 103.07M |
| Total Debt | 31.02M |
| Net Cash | 72.05M |
| Net Cash Per Share | $1.22 |
| Equity (Book Value) | 69.36M |
| Book Value Per Share | 1.17 |
| Working Capital | 99.40M |
Full Balance SheetCash Flow
| Operating Cash Flow | -38.34M |
| Capital Expenditures | n/a |
| Free Cash Flow | -38.34M |
| FCF Per Share | -$0.65 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |